BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3720216)

  • 1. Effect of influenza vaccine in patients receiving long-term warfarin therapy.
    Weibert RT; Lorentz SM; Norcross WA; Klauber MR; Jagger PI
    Clin Pharm; 1986 Jun; 5(6):499-503. PubMed ID: 3720216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy.
    Raj G; Kumar R; McKinney WP
    Arch Intern Med; 1995 Jul; 155(14):1529-31. PubMed ID: 7605155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study.
    Iorio A; Basileo M; Marcucci M; Guercini F; Camilloni B; Paccamiccio E; Vecchioli M; Iorio AM
    Arch Intern Med; 2010 Apr; 170(7):609-16. PubMed ID: 20386004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of influenza vaccine on warfarin anticoagulation in the elderly.
    Gomolin IH
    CMAJ; 1986 Jul; 135(1):39-41. PubMed ID: 3719485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin.
    MacCallum P; Madhani M; Mt-Isa S; Ashby D
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):786-9. PubMed ID: 17111459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccine and anticoagulation control in patients receiving warfarin.
    Arnold WS; Mehta MK; Roberts JS
    Br J Clin Pract; 1990 Apr; 44(4):136-9. PubMed ID: 2372474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting warfarin maintenance dosage based on initial response.
    Miller DR; Brown MA
    Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in prothrombin time and international normalized ratio over 24 hours in warfarin-treated patients.
    Bleske BE; Welage LS; Warren EW; Brown MB; Shea MJ
    Pharmacotherapy; 1995; 15(6):709-12. PubMed ID: 8602377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium.
    Crussell-Porter LL; Rindone JP; Ford MA; Jaskar DW
    Arch Intern Med; 1993 Jan; 153(1):102-4. PubMed ID: 8422191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal intracranial bleed potentially due to a warfarin and influenza vaccine interaction.
    Carroll DN; Carroll DG
    Ann Pharmacother; 2009 Apr; 43(4):754-60. PubMed ID: 19336651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation.
    Bianco TM; Bussey HI; Farnett LE; Linn WD; Roush MK; Wong YW
    Pharmacotherapy; 1992; 12(6):435-9. PubMed ID: 1492006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG; Feddersen C; Gulløv AL; Petersen P
    Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of influenza vaccination on international normalized ratio during chronic warfarin therapy.
    Kuo AM; Brown JN; Clinard V
    J Clin Pharm Ther; 2012 Oct; 37(5):505-9. PubMed ID: 22449298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose fluconazole for vulvovaginal candidiasis: impact on prothrombin time in women taking warfarin.
    Turrentine MA
    Obstet Gynecol; 2006 Feb; 107(2 Pt 1):310-3. PubMed ID: 16449117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study.
    Jackson ML; Nelson JC; Chen RT; Davis RL; Jackson LA;
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):790-6. PubMed ID: 17286320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of three dosage-prediction methods for initial in-hospital stabilization of warfarin therapy.
    Carter BL; Taylor JW; Becker A
    Clin Pharm; 1987 Jan; 6(1):37-45. PubMed ID: 3816105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy.
    Oberg KC
    Pharmacotherapy; 1998; 18(2):386-91. PubMed ID: 9545160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence, magnitude, and time course of the amiodarone-warfarin interaction.
    Kerin NZ; Blevins RD; Goldman L; Faitel K; Rubenfire M
    Arch Intern Med; 1988 Aug; 148(8):1779-81. PubMed ID: 3401099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.